Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case of maturity-onset diabetes of the young with a pathogenic HNF1A variant and a coexisting NEUROD1 variant.

Journal of diabetes investigation·2026
Same author

Influence of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on the management of blood pressure in Japanese patients with diabetes.

Hypertension research : official journal of the Japanese Society of Hypertension·2026
Same author

Long-term imaging characteristics of the pancreas related to diabetes induced by immune checkpoint inhibitor therapy.

Acta diabetologica·2026
Same author

Assay-Specific Diagnostic Thresholds for Adrenal Insufficiency: A Retrospective Comparison of Monoclonal Cortisol Measurements Using Roche Elecsys Cortisol II and Tosoh AIA-CL2400.

Cureus·2026
Same author

Sex differences in the impact of structured education together with isCGM in individuals with type 1 diabetes:post hoc analysis of the ISCHIA study.

The journal of medical investigation : JMI·2026
Same author

Pharmacotherapy as a catalyst for behaviour change.

BMJ (Clinical research ed.)·2026
Same journal

Ease of Use, Ease of Learning, and Convenience of the CagriSema Dual-Chamber Pen: Results From a Usability Study in Adults With Overweight, Obesity, or Type 2 Diabetes.

Journal of diabetes science and technology·2026
Same journal

Outcomes Following Infusion of Insulin Into Ultrasound-Detected Hyperechogenic Tissue in Youth Using Automated Insulin Delivery: A Paired Post Hoc Analysis.

Journal of diabetes science and technology·2026
Same journal

Automated Insulin Delivery Use Among Preschool-Age Children With Type 1 Diabetes: A T1D Exchange Multicenter Analysis.

Journal of diabetes science and technology·2026
Same journal

Mind the Gap: A Sequential 4-Step Missing Data Management for CGM-Derived Endpoints in Diabetes Clinical Trials.

Journal of diabetes science and technology·2026
Same journal

Changes in HbA1c With Glucagon-Like Peptide-1 Receptor Agonist Therapy Alone and Followed by Initiation of Continuous Glucose Monitoring: A Retrospective Analysis of U.S. Medical Claims Data.

Journal of diabetes science and technology·2026
Same journal

Performance and Safety of a 15-Day Real-Time Continuous Glucose Monitoring System in Chinese Adults With Diabetes: A Multicenter Trial.

Journal of diabetes science and technology·2026
See all related articles

Related Experiment Videos

Digital Intervention Increasing Sleep Duration Among People With Type 2 Diabetes: Pilot Randomized Controlled Trial.

Ryohei Nakada1, Daniel R Lane1, Shuya Iwata1

  • 1The University of Tokyo, Bunkyo-ku, Japan.

Journal of Diabetes Science and Technology
|May 6, 2026
PubMed
Summary
This summary is machine-generated.

Increasing sleep duration for individuals with type 2 diabetes did not significantly improve hemoglobin A1c (HbA1c) levels. This study suggests that modest sleep extension alone may not be sufficient for glycemic control in this population.

Keywords:
digital interventionmobile healthpersonalized interventionsleep durationtype 2 diabetes

Related Experiment Videos

Area of Science:

  • Endocrinology
  • Sleep Medicine
  • Digital Health Interventions

Background:

  • Short sleep duration is linked to poorer glycemic control, specifically higher hemoglobin A1c (HbA1c) levels.
  • Current guidelines recommend adequate sleep, but the impact of sleep extension on HbA1c in type 2 diabetes is not well-established.

Purpose of the Study:

  • To evaluate the effect of a personalized digital intervention aimed at increasing sleep duration on HbA1c levels in adults with type 2 diabetes.
  • To determine if extending sleep duration can lead to improved glycemic control.

Main Methods:

  • A single-blind, two-arm randomized controlled trial was conducted with 70 short-sleeping adults (≤6 hours) with type 2 diabetes in Japan.
  • Participants used actigraphy and sleep diaries to monitor sleep. The intervention group received personalized bedtime advancement support.
  • The primary outcome was the change in HbA1c after 12 weeks.

Main Results:

  • The intervention group achieved a statistically significant increase in sleep duration (average of 32.8 minutes).
  • Despite the sleep extension, there was no significant reduction in HbA1c levels in the intervention group compared to the control group.
  • No significant association was found between increased sleep duration and HbA1c reduction.

Conclusions:

  • A 12-week digital intervention leading to an average sleep extension of approximately 30 minutes did not significantly improve HbA1c in short-sleeping adults with type 2 diabetes.
  • Larger trials with more substantial sleep extension are needed to confirm any potential benefits.